Clinical Trials Browser

Interventional × selicrelumab × Lymphoid × Clear all

NCT03892525 2021-07-26

Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma

Phase 1 Terminated

Lymphoma, B-Cell